Free Trial

AIFU (AIFU) Competitors

AIFU logo
$4.30 -0.10 (-2.27%)
As of 10/17/2025 03:08 PM Eastern

AIFU vs. NEUE, AAME, TIRX, HUIZ, ZBAO, CNFR, OXBR, FGNX, FGF, and XHG

Should you be buying AIFU stock or one of its competitors? The main competitors of AIFU include NeueHealth (NEUE), Atlantic American (AAME), Tian Ruixiang (TIRX), Huize (HUIZ), Zhibao Technology (ZBAO), Conifer (CNFR), Oxbridge Re (OXBR), FG Nexus (FGNX), Fundamental Global (FGF), and XChange TEC.INC. (XHG). These companies are all part of the "insurance" industry.

AIFU vs. Its Competitors

AIFU (NASDAQ:AIFU) and NeueHealth (NYSE:NEUE) are both small-cap insurance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

In the previous week, AIFU had 1 more articles in the media than NeueHealth. MarketBeat recorded 1 mentions for AIFU and 0 mentions for NeueHealth. AIFU's average media sentiment score of 0.00 equaled NeueHealth'saverage media sentiment score.

Company Overall Sentiment
AIFU Neutral
NeueHealth Neutral

AIFU has higher earnings, but lower revenue than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than AIFU, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AIFU$247.81M0.05$62.33M$0.735.89
NeueHealth$890.44M0.07-$134.68M-$15.97-0.42

AIFU has a net margin of 0.00% compared to NeueHealth's net margin of -9.08%.

Company Net Margins Return on Equity Return on Assets
AIFUN/A N/A N/A
NeueHealth -9.08%N/A -13.01%

AIFU has a beta of 0.49, suggesting that its share price is 51% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500.

NeueHealth has a consensus target price of $7.00, indicating a potential upside of 3.66%. Given NeueHealth's higher possible upside, analysts clearly believe NeueHealth is more favorable than AIFU.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AIFU
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
NeueHealth
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

26.7% of AIFU shares are owned by institutional investors. Comparatively, 63.9% of NeueHealth shares are owned by institutional investors. 25.6% of AIFU shares are owned by insiders. Comparatively, 63.3% of NeueHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

AIFU beats NeueHealth on 7 of the 13 factors compared between the two stocks.

Get AIFU News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIFU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIFU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIFU vs. The Competition

MetricAIFUINS IndustryFinance SectorNASDAQ Exchange
Market Cap$12.74M$20.69B$12.51B$10.50B
Dividend YieldN/A2.70%5.60%4.81%
P/E Ratio5.8913.0232.5927.09
Price / Sales0.052.1329.77210.72
Price / Cash0.1917.2222.2461.22
Price / Book0.033.352.236.52
Net Income$62.33M$1.62B$1.02B$276.75M
7 Day Performance-14.00%-1.29%0.27%2.00%
1 Month Performance-34.85%-5.22%-2.45%2.26%
1 Year PerformanceN/A9.31%533.73%35.58%

AIFU Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIFU
AIFU
1.657 of 5 stars
$4.30
-2.3%
N/AN/A$12.74M$247.81M5.894,707High Trading Volume
NEUE
NeueHealth
1.1919 of 5 stars
$6.75
flat
$7.00
+3.7%
N/A$60.94M$890.44M-0.421,252
AAME
Atlantic American
1.4408 of 5 stars
$2.97
+6.8%
N/A+86.5%$58.85M$188.23M28.85140News Coverage
TIRX
Tian Ruixiang
0.7389 of 5 stars
$2.31
-4.0%
N/A-88.8%$56.15M$3.22M0.0050Gap Up
HUIZ
Huize
1.3328 of 5 stars
$3.69
-2.3%
$2.30
-37.6%
-82.3%$37.74M$171.10M124.671,640Short Interest ↓
ZBAO
Zhibao Technology
N/A$0.97
-9.9%
N/A-73.4%$30.67M$25.27M0.00148Positive News
Short Interest ↑
CNFR
Conifer
0.9123 of 5 stars
$1.51
+27.2%
N/A+41.5%$18.50M$52.03M0.62150Gap Down
OXBR
Oxbridge Re
2.2934 of 5 stars
$2.03
+8.0%
$5.00
+146.3%
-32.9%$15.47M$550K-4.943Short Interest ↓
Gap Up
FGNX
FG Nexus
3.0092 of 5 stars
$5.70
-2.6%
N/AN/A$7.58M$17.35M0.009News Coverage
Analyst Forecast
Gap Up
FGF
Fundamental Global
N/A$5.85
+0.3%
N/A-85.0%$7.52M$13.26M4.479Gap Up
XHG
XChange TEC.INC.
N/A$1.29
+0.8%
N/A-98.7%$26K$41.09M0.0030Negative News
Short Interest ↓
Gap Up

Related Companies and Tools


This page (NASDAQ:AIFU) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners